An enhanced recovery pathway and health-related quality of life in adults with type 2 diabetes: A randomised controlled trial
Published
December 29, 2024
Paper ID
PAP-000129
Status
Published
DOI
10.65712/tmj.test000387
Advance Services
Abstract
Background: Earlier studies of an enhanced recovery pathway were small or single-centre. Methods: We conducted a randomised controlled trial across 6 centres between 2019 and 2021. Results: The adjusted odds ratio was 0.83 (95% CI 0.35 to 0.71). Effects were consistent across prespecified subgroups. Conclusion: Strengths include the sample size and blinded outcome assessment.
References
1. Rahman K, Tanaka Z, et al. Delayed cord clamping and ventilator-free days. Diabetes Care. 2021;399(11):590-1302.
2. Haddad F, Silva T, et al. Frailty screening and acute kidney injury. Diabetes Care. 2013;57(8):302-1229.
3. Rossi R, Volkov F, et al. Early mobilisation and ventilator-free days. Eur Heart J. 2011;266(1):334-1650.
4. Yilmaz L, Farouk Q, et al. Machine-learning triage and medication adherence. BMC Med. 2025;287(5):713-1114.
5. Herrera C, Schmidt S, et al. Telemedicine follow-up and in-hospital mortality. Ann Intern Med. 2012;160(3):691-1246.
6. Osei F, Lindqvist E, et al. SGLT2 inhibitors and time to diagnosis. BMC Med. 2012;248(1):637-1775.
7. Andersen O, Mueller J, et al. A sepsis alert system and emergency department revisits. BMC Med. 2018;157(1):117-1338.
8. Zhang W, Mueller K, et al. Machine-learning triage and glycaemic control. JAMA. 2019;108(12):454-1016.
9. Yilmaz I, Dubois Q, et al. High-flow nasal oxygen and length of stay. Diabetes Care. 2022;274(10):695-1766.
10. Costa E, Yilmaz J, et al. A sepsis alert system and length of stay. Pediatrics. 2022;249(3):692-1763.
Introduction
Practice around an enhanced recovery pathway varies widely between centres. Guidelines make only a weak recommendation on an enhanced recovery pathway.
Guidelines make only a weak recommendation on an enhanced recovery pathway. health-related quality of life remains a leading cause of avoidable harm among adults with type 2 diabetes.
health-related quality of life remains a leading cause of avoidable harm among adults with type 2 diabetes. The cost of health-related quality of life to health systems is substantial.
Practice around an enhanced recovery pathway varies widely between centres. health-related quality of life remains a leading cause of avoidable harm among adults with type 2 diabetes.
Materials and Methods
Analyses were adjusted for age, sex and baseline severity. We conducted a randomised controlled trial across 3 centres between 2016 and 2021.
Analyses were adjusted for age, sex and baseline severity.
Analyses were adjusted for age, sex and baseline severity. We conducted a randomised controlled trial across 10 centres between 2018 and 2024. We conducted a randomised controlled trial across 12 centres between 2017 and 2021. The primary outcome was health-related quality of life, assessed blind to allocation.
We conducted a randomised controlled trial across 9 centres between 2019 and 2021. We conducted a randomised controlled trial across 12 centres between 2015 and 2024. We conducted a randomised controlled trial across 4 centres between 2019 and 2022.
Results
Effects were consistent across prespecified subgroups. Serious adverse events were rare and similar between groups.
| Group | n | Events |
|---|---|---|
| Female | 890 | 81 |
| Male | 760 | 47 |
| Intervention | 33 | 109 |
| Control | 411 | 119 |
| Male | 880 | 12 |
| Centre A | 422 | 12 |
| Female | 659 | 33 |
Values are n (%) unless stated otherwise.

Shown for adults with type 2 diabetes; error bars are 95% confidence intervals.

Shown for adults with type 2 diabetes; error bars are 95% confidence intervals.
Serious adverse events were rare and similar between groups. The adjusted odds ratio was 0.83 (95% CI 0.46 to 0.78).
Serious adverse events were rare and similar between groups. The adjusted odds ratio was 0.54 (95% CI 0.41 to 0.76). Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.77 (95% CI 0.44 to 0.73).
Discussion
Future work should test an enhanced recovery pathway in a pragmatic multicentre trial. Residual confounding cannot be excluded.
Residual confounding cannot be excluded. Strengths include the sample size and blinded outcome assessment. These findings suggest that an enhanced recovery pathway is associated with better health-related quality of life in adults with type 2 diabetes.
Implementation will depend on staffing, cost and local protocols. These findings suggest that an enhanced recovery pathway is associated with better health-related quality of life in adults with type 2 diabetes.
Residual confounding cannot be excluded. Implementation will depend on staffing, cost and local protocols.
Residual confounding cannot be excluded. Implementation will depend on staffing, cost and local protocols. These findings suggest that an enhanced recovery pathway is associated with better health-related quality of life in adults with type 2 diabetes.
Conclusions
An enhanced recovery pathway should be considered for adults with type 2 diabetes to improve health-related quality of life.
Appendices
Supplementary tables are available on request.